We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
74 hedge funds and large institutions have $130M invested in ADMA Biologics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
113% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 15
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
3% more funds holding
Funds holding: 72 → 74 (+2)
7.96% less ownership
Funds ownership: 62.69% → 54.73% (-8%)
16% less call options, than puts
Call options by funds: $107K | Put options by funds: $128K
22% less capital invested
Capital invested by funds: $165M → $130M (-$35.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
32
Reduced
15
Closed
13
Calls
$107K
Puts
$128K
Net Calls
-$21K
Net Calls Change
-$286K
Top Buyers
| 1 |
BlackRock
New York
|
+$3.6M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.35M |
| 3 |
Goldman Sachs
New York
|
+$981K |
| 4 |
State Street
Boston,
Massachusetts
|
+$641K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$632K |
Top Sellers
| 1 |
6CM
683 Capital Management
New York
|
-$3.16M |
| 2 |
Millennium Management
New York
|
-$2.6M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$2.44M |
| 4 |
BC
Broadfin Capital
New York
|
-$2.25M |
| 5 |
JG
Jefferies Group
New York
|
-$2.23M |
